Comparison of Phenotype and Outcome in Microscopic Polyangiitis Between Europe and Japan

Objective. There are differences between Europe and Japan in the incidence and antineutrophil cytoplasmic antibody (ANCA) serotype of patients with microscopic polyangiitis (MPA). However, differences in phenotype or outcome have not been explored. We aimed to identify differences in phenotype and outcome of MPA between Europe and Japan. Methods. Sequential cohorts of patients with MPA and renal limited vasculitis were collected from European and Japanese centers (n = 147 and n = 312, respectively). Trial databases from the European Vasculitis Society and the Japanese patients with Myeloperoxidase (MPO)-ANCA-Associated Vasculitis (JMAAV) trial were studied (n = 254 and n = 48, respectively). We evaluated baseline characteristics including ANCA status and organ involvement, treatment, survival, and renal survival. Differences in survival and renal survival were studied using multivariate analysis. Results. The non-trial cohorts showed patients with MPA in Japan had a higher age at onset, more frequent MPO-ANCA positivity, lower serum creatinine, and more frequent interstitial pneumonitis than those in Europe (all p < 0.01). Comparisons between the trial databases demonstrated similar results. Cumulative patient survival and renal survival rates were not different between Europe and Japan (p = 0.71 and p = 0.38, respectively). Multivariate analysis identified age at onset, serum creatinine, gastrointestinal, and respiratory involvement as factors with higher risk of death. For endstage renal failure, serum creatinine and use of plasma exchange were identified as factors with higher risk, and immunosuppressant use as lower risk factors. Conclusion. Phenotypes in patients with MPA were different between Europe and Japan. However, the outcomes of patient survival and renal survival were similar.

[1]  Rohit Sharma.  Revised International Chapel Hill Consensus Conference nomenclature of vasculitides , 2016, Radiopaedia.org.

[2]  D. Jayne,et al.  Antineutrophil cytoplasm antibody-associated vasculitis: recent developments. , 2013, Kidney international.

[3]  T. Sugiyama,et al.  Evaluation of the newly proposed simplified histological classification in Japanese cohorts of myeloperoxidase-anti-neutrophil cytoplasmic antibody-associated glomerulonephritis in comparison with other Asian and European cohorts , 2012, Clinical and Experimental Nephrology.

[4]  Yichun Hu,et al.  Classification of antineutrophil cytoplasmic autoantibody vasculitides: the role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis. , 2012, Arthritis and rheumatism.

[5]  Sandrine Katsahian,et al.  Revisiting the classification of clinical phenotypes of anti-neutrophil cytoplasmic antibody-associated vasculitis: a cluster analysis , 2012, Annals of the rheumatic diseases.

[6]  Panos Deloukas,et al.  Genetically distinct subsets within ANCA-associated vasculitis. , 2012, The New England journal of medicine.

[7]  K. Nitta,et al.  ANCA-associated systemic vasculitis in Japan: clinical features and prognostic changes , 2012, Clinical and Experimental Nephrology.

[8]  D. Scott,et al.  Comparison of the epidemiology of anti-neutrophil cytoplasmic antibody-associated vasculitis between Japan and the U.K. , 2011, Rheumatology.

[9]  Y. Tomino,et al.  Severity-based treatment for Japanese patients with MPO-ANCA-associated vasculitis: the JMAAV study , 2011, Modern rheumatology.

[10]  J. del Pino-Montes,et al.  Overall survival, renal survival and relapse in patients with microscopic polyangiitis: a systematic review of current evidence. , 2011, Rheumatology.

[11]  Shinji Sato,et al.  Clinically amyopathic dermatomyositis , 2010, Current opinion in rheumatology.

[12]  Irmgard Neumann,et al.  Histopathologic classification of ANCA-associated glomerulonephritis. , 2010, Journal of the American Society of Nephrology : JASN.

[13]  L. Jacobsson,et al.  Incidence and survival rates in Wegener's granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and polyarteritis nodosa. , 2009, Rheumatology.

[14]  Kenneth G. C. Smith,et al.  Confirmation of the genetic association of CTLA4 and PTPN22 with ANCA-associated vasculitis , 2009, BMC Medical Genetics.

[15]  Y. Saeki,et al.  Factors associated with fatal outcome of leflunomide-induced lung injury in Japanese patients with rheumatoid arthritis. , 2009, Rheumatology.

[16]  David Steven Scott,et al.  Modification and validation of the Birmingham Vasculitis Activity Score (version 3) , 2008, Annals of the rheumatic diseases.

[17]  D. Scott,et al.  Renal vasculitis in Japan and the UK--are there differences in epidemiology and clinical phenotype? , 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[18]  M. Cook,et al.  Epidemiology of primary systemic vasculitis in the Australian Capital Territory and south‐eastern New South Wales , 2008, Internal medicine journal.

[19]  J. Krischer,et al.  Comparison of disease activity measures for anti-neutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis , 2008, Annals of the rheumatic diseases.

[20]  S. Kudoh,et al.  Basis of acute exacerbation of idiopathic pulmonary fibrosis in Japanese patients. , 2008, American journal of respiratory and critical care medicine.

[21]  M. Nothnagel,et al.  The Wegener’s granulomatosis quantitative trait locus on chromosome 6p21.3 as characterised by tagSNP genotyping , 2007, Annals of the rheumatic diseases.

[22]  D. Abramowicz,et al.  Randomized trial of plasma exchange or high-dosage methylprednisolone as adjunctive therapy for severe renal vasculitis. , 2007, Journal of the American Society of Nephrology : JASN.

[23]  Kazuo Suzuki,et al.  Incidence of ANCA-associated primary renal vasculitis in the Miyazaki Prefecture: the first population-based, retrospective, epidemiologic survey in Japan. , 2006, Clinical journal of the American Society of Nephrology : CJASN.

[24]  J. Krischer,et al.  Current status of outcome measures in vasculitis: focus on Wegener's granulomatosis and microscopic polyangiitis. Report from OMERACT 7. , 2005, The Journal of rheumatology.

[25]  F. Yu,et al.  Cinical and pathological characteristics of Chinese patients with antineutrophil cytoplasmic autoantibody associated systemic vasculitides: a study of 426 patients from a single centre , 2005, Postgraduate Medical Journal.

[26]  C. Feighery,et al.  Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis. , 2005, Arthritis and rheumatism.

[27]  R. Wagner-Bastmeyer,et al.  Stable incidence of primary systemic vasculitides over five years: results from the German vasculitis register. , 2005, Arthritis and rheumatism.

[28]  V. Tesar,et al.  A randomized trial of maintenance therapy for vasculitis associated with antineutrophil cytoplasmic autoantibodies. , 2003, The New England journal of medicine.

[29]  M. González-Gay,et al.  The epidemiology of the primary systemic vasculitides in northwest Spain: implications of the Chapel Hill Consensus Conference definitions. , 2003, Arthritis and rheumatism.

[30]  G. Kitas,et al.  Disease assessment and management of the vasculitides. , 1997, Bailliere's clinical rheumatology.

[31]  R. Moots,et al.  Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. , 1994, QJM : monthly journal of the Association of Physicians.

[32]  R J Falk,et al.  Nomenclature of systemic vasculitides. Proposal of an international consensus conference. , 1994, Arthritis and rheumatism.

[33]  P. Merkel,et al.  2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. , 2013, Arthritis and rheumatism.

[34]  M. Nakayama,et al.  Clinical outcomes of Japanese MPO-ANCA-related nephritis: significance of initial renal death for survival. , 2012, Internal medicine.

[35]  K. Tokunaga,et al.  Association of HLA-DRB1*0901-DQB1*0303 haplotype with microscopic polyangiitis in Japanese , 2006, Genes and Immunity.

[36]  Hans C van Houwelingen,et al.  Renal histology in ANCA-associated vasculitis: differences between diagnostic and serologic subgroups. , 2002, Kidney international.

[37]  K. De Groot,et al.  Development and validation of a disease extent index for Wegener's granulomatosis. , 2001, Clinical nephrology.